- Home
- PYXS vs PETS Comparison
PYXS vs PETS Comparison
Compare PYXS & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYXS
- PETS
- Stock Information
- Founded
- PYXS 2018
- PETS 1996
- Country
- PYXS United States
- PETS United States
- Employees
- PYXS N/A
- PETS N/A
- Industry
- PYXS Biotechnology: Pharmaceutical Preparations
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- PYXS Health Care
- PETS Consumer Staples
- Exchange
- PYXS Nasdaq
- PETS Nasdaq
- Market Cap
- PYXS 66.3M
- PETS 62.8M
- IPO Year
- PYXS 2021
- PETS N/A
- Fundamental
- Price
- PYXS $1.22
- PETS $3.82
- Analyst Decision
- PYXS Strong Buy
- PETS Sell
- Analyst Count
- PYXS 5
- PETS 2
- Target Price
- PYXS $9.00
- PETS $3.35
- AVG Volume (30 Days)
- PYXS 411.8K
- PETS 108.7K
- Earning Date
- PYXS 05-15-2025
- PETS 06-10-2025
- Dividend Yield
- PYXS N/A
- PETS N/A
- EPS Growth
- PYXS N/A
- PETS N/A
- EPS
- PYXS N/A
- PETS 0.02
- Revenue
- PYXS N/A
- PETS $247,010,000.00
- Revenue This Year
- PYXS N/A
- PETS N/A
- Revenue Next Year
- PYXS N/A
- PETS N/A
- P/E Ratio
- PYXS N/A
- PETS $216.24
- Revenue Growth
- PYXS N/A
- PETS N/A
- 52 Week Low
- PYXS $0.83
- PETS $2.90
- 52 Week High
- PYXS $5.39
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- PYXS 55.44
- PETS 54.50
- Support Level
- PYXS $1.20
- PETS $3.56
- Resistance Level
- PYXS $1.20
- PETS $3.82
- Average True Range (ATR)
- PYXS 0.08
- PETS 0.19
- MACD
- PYXS 0.00
- PETS -0.00
- Stochastic Oscillator
- PYXS 80.85
- PETS 43.33
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.